Skip to main content

Table 3 Multivariate analysis of risk factors for CNS relapse in the entire cohort

From: New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study

Variable

HR

95% CI

P

Bone involvement

4.21

1.38–12.77

0.011

Kidney involvement

3.85

1.05–14.19

0.043

ALP > 110U/L

3.59

1.25–10.34

0.018

ALB < 35g/L

3.63

1.25–10.51

0.018

Rituximab treatment

0.34

0.12–0.96

0.042

TTC ≤ 108 days

0.22

0.06–0.78

0.019

  1. HR hazard ratio, CI confidence interval. Other abbreviations as in Table 1